1 – 10 of 12
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
NT-rådet underminerar riksdagens plattform för prioriteringar
(
- Contribution to specialist publication or newspaper › Specialist publication article
- 2007
-
Mark
Therapeutic drug monitoring of escitalopram in an outpatient setting
(
- Contribution to journal › Article
- 2006
-
Mark
Sustained citalopram treatment in experimental hepatic encephalopathy: Effects on entrainment to the light-dark cycle and melatonin
(
- Contribution to journal › Article
-
Mark
Quantitative studies of liver atrophy after portacaval shunt in the rat
(
- Contribution to journal › Article
- 2003
-
Mark
Therapeutic Drug Monitoring of Racemic Citalopram: A 5-Year Experience in Sweden, 1992-1997.
(
- Contribution to journal › Article
- 2002
-
Mark
Effects of chronic citalopram treatment on central and peripheral spontaneous open-field behaviours in rats
(
- Contribution to journal › Article
-
Mark
Therapeutic drug monitoring of racemic venlafaxine and its main metabolites in an everyday clinical setting.
(
- Contribution to journal › Article
-
Mark
Effects on drug disposition, brain monoamines and behavior after chronic treatment with the antidepressant venlafaxine in rats with experimental hepatic encephalopathy.
(
- Contribution to journal › Article
-
Mark
Disposition of venlafaxine enantiomers in rats with hepatic encephalopathy after chronic drug treatment.
(
- Contribution to journal › Article
- 1998
-
Mark
Cyclosporin A, but not FK 506, protects mitochondria and neurons against hypoglycemic damage and implicates the mitochondrial permeability transition in cell death
(
- Contribution to journal › Article